Published in Mol Carcinog on October 01, 2001
Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition. Cancer Res (2009) 1.15
Novel gene expression patterns along the proximo-distal axis of the mouse embryo before gastrulation. BMC Dev Biol (2007) 1.05
Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. Br J Cancer (2006) 0.97
Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm. World J Gastroenterol (2004) 0.83
Down-regulation of NDRG1 promotes migration of cancer cells during reoxygenation. PLoS One (2011) 0.81
MicroRNA-769-3p down-regulates NDRG1 and enhances apoptosis in MCF-7 cells during reoxygenation. Sci Rep (2014) 0.81
Oncogenic but non-essential role of N-myc downstream regulated gene 1 in the progression of esophageal squamous cell carcinoma. Cancer Biol Ther (2012) 0.79
Global gene expression analysis reveals a link between NDRG1 and vesicle transport. PLoS One (2014) 0.79
Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways. Mol Med Rep (2015) 0.79
Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity. World J Gastroenterol (2007) 0.78
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet (2000) 12.56
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax (2005) 7.39
The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med (2001) 5.95
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet (1998) 4.16
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci (1999) 3.45
Skin and hair follicle integrity is crucially dependent on beta 1 integrin expression on keratinocytes. EMBO J (2000) 3.32
An anorexic lipid mediator regulated by feeding. Nature (2001) 2.94
A conserved RNA structure (thi box) is involved in regulation of thiamin biosynthetic gene expression in bacteria. Proc Natl Acad Sci U S A (2001) 2.88
Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J (2001) 2.83
Renal injury in the extremely obese patients with normal renal function. Kidney Int (2008) 2.83
Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med (1998) 2.68
Sequences 5' of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation (1994) 2.53
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science (1997) 2.50
Induction of cyclin D1 overexpression by activated ras. Oncogene (1994) 2.35
Patterns of expression and organization of cytokeratin intermediate filaments. Ann N Y Acad Sci (1985) 2.21
Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment. Proc Natl Acad Sci U S A (1998) 2.10
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog (1999) 1.95
Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev (1998) 1.88
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol (2009) 1.81
Differentially expressed bovine cytokeratin genes. Analysis of gene linkage and evolutionary conservation of 5'-upstream sequences. EMBO J (1987) 1.80
Standardized approach for microsatellite instability detection in colorectal carcinomas. J Natl Cancer Inst (2000) 1.80
High-resolution PLA-based composite scaffolds via 3-D printing technology. Acta Biomater (2012) 1.67
VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene (1998) 1.61
Detection of loss of heterozygosity in formalin-fixed paraffin-embedded tumor specimens by the polymerase chain reaction. Am J Pathol (1991) 1.59
High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature (1995) 1.57
p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst (1993) 1.54
International collaborative study on standardization of bacterial sensitivity to fosfomycin. J Antimicrob Chemother (1983) 1.52
Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Proc Natl Acad Sci U S A (1996) 1.51
In vitro core particle and nucleosome assembly at physiological ionic strength. Proc Natl Acad Sci U S A (1979) 1.50
p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential. J Urol (1999) 1.46
alpha-Interferon therapy for congenital dyserythropoiesis type I. Br J Haematol (1995) 1.46
Reengineering respiratory support following extubation: avoidance of critical care unit costs. Chest (1999) 1.39
Technical improvements in corrosion casting of small specimens: a study on mesonephric tubules and vessels of chicken embryos. Scanning Microsc (1993) 1.39
Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc Natl Acad Sci U S A (1998) 1.38
Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res (1995) 1.36
De novo synthesis and specific assembly of keratin filaments in nonepithelial cells after microinjection of mRNA for epidermal keratin. Cell (1983) 1.36
Molecular determinants of Akt-induced keratinocyte transformation. Oncogene (2006) 1.34
Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res (1999) 1.33
Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. J Neurosci (2000) 1.31
Identification of two types of keratin polypeptides within the acidic cytokeratin subfamily I. J Mol Biol (1984) 1.31
Modulation of cell proliferation by cytokeratins K10 and K16. Mol Cell Biol (1999) 1.30
E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol (1999) 1.29
Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31. Nat Genet (2001) 1.28
Cell type-specific expression of bovine keratin genes as demonstrated by the use of complementary DNA clones. J Mol Biol (1984) 1.28
Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy (2007) 1.27
Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br J Cancer (2004) 1.27
Chagas disease in Latin American migrants: a Spanish challenge. Clin Microbiol Infect (2010) 1.27
Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene (1998) 1.25
Participation of cytoskeletal intermediate filaments in the infectious cycle of human respiratory syncytial virus (RSV). Virus Res (1988) 1.25
Significance of two desmosome plaque-associated polypeptides of molecular weights 75 000 and 83 000. EMBO J (1983) 1.24
(C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci U S A (1994) 1.24
Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res (1994) 1.23
Elements controlling the expression and induction of the skin hyperproliferation-associated keratin K6. J Biol Chem (1995) 1.23
Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene (1993) 1.22
Hair cycle and wound healing in mice with a keratinocyte-restricted deletion of FAK. Oncogene (2006) 1.22
Translational products of mRNAs coding for non-epidermal cytokeratins. EMBO J (1983) 1.22
Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors. Proc Natl Acad Sci U S A (1990) 1.20
PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. Oncogene (1999) 1.19
Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy. Proc Natl Acad Sci U S A (1987) 1.19
Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A. Curr Biol (1996) 1.17
The molecular karyotype of the megabase chromosomes of Trypanosoma brucei stock 427. Mol Biochem Parasitol (2000) 1.16
H3.H4 tetramer directs DNA and core histone octamer assembly in the nucleosome core particle. Biochemistry (1979) 1.16
Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats. Cell Growth Differ (1996) 1.15
Inhibition of protein kinase B (PKB) and PKCzeta mediates keratin K10-induced cell cycle arrest. Mol Cell Biol (2001) 1.15
Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis (1995) 1.14
Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res (1996) 1.13
ras activity and cyclin D1 expression: an essential mechanism of mouse skin tumor development. Mol Carcinog (1999) 1.12
Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis (1991) 1.12
Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats. Metabolism (2000) 1.11
A variant of pulmonary alveolar microlithiasis in nackt mice. Vet Pathol (2002) 1.11
Exocrine pancreatic disorders in transsgenic mice expressing human keratin 8. J Clin Invest (1999) 1.11
Regulation of vsg expression site transcription and switching in Trypanosoma brucei. Mol Biochem Parasitol (1998) 1.11
Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in Dermatofibrosarcoma protuberans (DP). Oncogene (2001) 1.10
Enhancer elements directing cell-type-specific expression of cytokeratin genes and changes of the epithelial cytoskeleton by transfections of hybrid cytokeratin genes. EMBO J (1989) 1.10
Isolation and characterization of Drosophila melanogaster U2 small nuclear RNA genes. J Mol Biol (1983) 1.10
Complete sequence of a bovine type I cytokeratin gene: conserved and variable intron positions in genes of polypeptides of the same cytokeratin subfamily. EMBO J (1985) 1.10
Changes in proteasome localization during the cell cycle. Eur J Cell Biol (1994) 1.10
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy. Br J Cancer (2010) 1.10
p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes. Oncogene (2011) 1.09
Integration of different keratins into the same filament system after microinjection of mRNA for epidermal keratins into kidney epithelial cells. Cell (1984) 1.09
Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium- and rhodium-chloroquine complexes. J Med Chem (1996) 1.09
An octamer of core histones in solution: central role of the H3-H4 tetramer in the self-assembly. Biochemistry (1979) 1.09
Leukemia-associated changes identified by quantitative flow cytometry. II. CD5 over-expression and monitoring in B-CLL. Leukemia (1994) 1.09
Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells. J Biol Chem (2000) 1.08
Inverse paradoxical embolism in a patient on chronic hemodialysis with aortic bacterial endocarditis. Am J Kidney Dis (1999) 1.07
Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis. Oncogene (1999) 1.07
Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions. Mol Carcinog (1989) 1.06
Differential expression and functionally co-operative roles for the retinoblastoma family of proteins in epidermal differentiation. Oncogene (1998) 1.06